https://www.selleckchem.com/products/tl12-186.html
BACKGROUND Evidence on access to reperfusion therapy for patients with ST-segment elevation myocardial infarction (STEMI) and associated mortality in developing countries is scarce. This study determined time trends in the nationally aggregated reperfusion and mortality, examined distribution of percutaneous coronary intervention (PCI) utilization across provinces, and assessed the reperfusion-mortality association in Thailand that achieved universal health coverage in 2002. METHODS Data on hospitalization with STEMI in 2011-2017 of 69
Like
Comment
Share
